Worldwide dispatch from Hong Kong · orders reserved 24 h · dispatched within 2 business daysAccountOrdersUSD

Semaglutide

Peptide · Sequence Library

Buy Semaglutide for research use from Seqvanta. Choose from 2 published package presentations and review the published presentation before checkout.

Offer
Published USD offer
Options
2 package options
Intended use
Research use only
Product photograph coming soon

Choose your package

Pick the package size that fits your order

Semaglutide has 2 published package options. Select the row that matches your requested amount; each price is per package.

Select a package2 options
Your selection
10 mg / 1 vial$188.50 per package
1–999 packages

At a glance

Package details

Format
Lyophilized powder
Pack type
Vial

Before you order

About Semaglutide

Buy Semaglutide for research use from Seqvanta. Package prices run from $188.50-$455.00 USD per package across 2 published package presentations; package content is 10 mg, 30 mg. Choose the presentation that matches your request, then review quality and shipping notes before checkout.

Product overview

What you’re buying

Peptide · The page keeps the named peptide separate from sequence, purity and clinical claims.

Identity

What Semaglutide refers to

Semaglutide has a published catalog identity. Use the identity note below with the receiving brief; the name alone does not establish equivalence.

Canonical name
Semaglutide
Catalog class
Sequence-based material
Catalog category
Sequence Library
Identity status
Catalog identity published
Material context
research material; catalog identity published

Before you order

Make sure the listing matches your method

Use this section to match Semaglutide to the protocol and receiving requirements; the catalog class does not establish sequence, purity, efficacy, approval, or human-use suitability.

  • Confirm sequence, length, modifications and batch documents when your method needs them.
  • Match the canonical Semaglutide product to the protocol or purchase request before comparing offers.
  • Use the package fields and price as the purchasing boundary.

Published research

What researchers have studied

Research foundChecked 2026-09-13

Indexed PubMed records were found for this product name or a registered alias. They are research references, not proof that a specific batch is equivalent or clinically effective.

2026Human study

Association of Tirzepatide versus Semaglutide with Risk of Asthma Exacerbation in Patients with Asthma and Type 2 Diabetes: A US Multicenter Retrospective Cohort Study.

Indexed human study; review the original publication for its design, population and outcomes.

Human publication; review the study design and population before drawing conclusions.

Read the paper
2026Human study

Postoperative outcomes after total knee arthroplasty in type 2 diabetes mellitus patients receiving semaglutide versus tirzepatide: a propensity score-matched national research network analysis.

Indexed human study; review the original publication for its design, population and outcomes.

Human publication; review the study design and population before drawing conclusions.

Read the paper
2026Review

Comparative Efficacy and Safety of Tirzepatide Versus Semaglutide for Obesity: A Systematic Review.

Review article that summarises earlier work; it does not add a new clinical outcome.

Review article; it summarises prior work rather than adding a new human outcome.

Read the paper
2026Review

International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update.

Review article that summarises earlier work; it does not add a new clinical outcome.

Review article; it summarises prior work rather than adding a new human outcome.

Read the paper
2026Review

Improvement of small fiber neuropathy assessed by corneal confocal microscopy following semaglutide treatment: a case report and literature review.

Review article that summarises earlier work; it does not add a new clinical outcome.

Review article; it summarises prior work rather than adding a new human outcome.

Read the paper
2024Review

Oral Adverse Effects of Semaglutide Therapy: A Narrative Review.

Review article that summarises earlier work; it does not add a new clinical outcome.

Review article; it summarises prior work rather than adding a new human outcome.

Read the paper
How to read this: ClinicalTrials.gov returned 77 matching registered record(s); registration is not the same as a published result. The studies are context for research procurement, not a promise of safety, dosing or benefit.

Documents and checks

What is published — and what to request

The details are grouped by the decision they support. Prices and package choices stay in the purchase panel above.

Documentation available for Semaglutide

For Semaglutide, verify identity, package presentation, and the analytical evidence required by the receiving method against a batch or analytical document that matches the receiving method. A lot-specific certificate of analysis is not published for Semaglutide; request the required evidence before payment.

Public package fields
content, form, and container
Evidence request
Request required batch or analytical documents before payment
SDS / safety data sheet
Not published on this page; request document
CAS number
Not published in the public catalog; request document
Concentration
Not published in the selected package rows; request document
Species reactivity
Not published in the public catalog; request method-specific document
Authenticity / chain of custody
No independent verification is published; request batch traceability documentation
Supplier reviews / rating
No public supplier reviews or rating are published
  • The public page shows the sequence-based material identity, package presentation, and current USD amount for Semaglutide where available.
  • A lot-specific certificate of analysis and independent laboratory result are not published for Semaglutide; request the batch or analytical documents required by the receiving process.
  • For this identity, package presentation, and the analytical evidence required by the receiving method check, an absent value stays a document request rather than a claim inferred from the product name.
Handling questions to resolve for Semaglutide

Confirm storage, shelf-life, transport, and stability requirements for the selected Semaglutide package before ordering. Do not infer research-material handling from a prescription product.

Storage specification
Not published in the public catalog
Shelf-life / stability
Not published in the public catalog
Transport / cold chain
Not published in the public catalog
  • Storage specification for Semaglutide: Not published in the public catalog.
  • Shelf-life and stability: Not published in the public catalog.
  • Transport or cold-chain requirement: Not published in the public catalog.
  • Keep release decisions with the receiving laboratory SOP and confirm any product-specific requirement before ordering.
Quality specifications to verify for Semaglutide

A research-grade or purity decision for Semaglutide needs evidence that matches the receiving method. The public page does not turn an absent purity, bioactivity, endotoxin, or grade value into a claim; resolve the identity, package presentation, and the analytical evidence required by the receiving method questions before relying on this product.

Public purity / grade value
Not published in the public catalog
Public analytical result
Not published on this page; request the relevant document
Evidence request
Request the method, acceptance criteria, and batch document before payment
  • For Semaglutide, the useful quality check is identity, package presentation, and the analytical evidence required by the receiving method.
  • A numeric purity, research-grade, bioactivity, or endotoxin value is not published in the public catalog unless it appears in the selected presentation or a document supplied for review.
  • Ask for the method, acceptance criteria, and batch traceability your receiving process requires; a product name is not a test result.
How to evaluate a source for Semaglutide

For Semaglutide, supplier evaluation means checking the identity evidence and traceability required by the receiving process. Commercial dispatch and reservation terms are listed separately.

Seller shown to buyers
Seqvanta
Public review score
Not published in the public catalog
Independent verification
Not claimed on this page
Evaluation basis
Identity, presentation, documentation, and traceability evidence
  • Evaluate the Semaglutide source against canonical identity and package presentation; a product name alone is not a supplier assessment.
  • Check whether the documentation and traceability meet the receiving process.
  • Use public reviews only as supplementary context; no independent supplier score is published here.
More product details

Technical specifications published for Semaglutide

The technical view for Semaglutide covers identity fields that are not repeated in the package offer. Missing molecular or analytical values stay unconfirmed until the relevant listing or document supplies them.

Catalog classification
research material
Identity-linked technical fields
CAS, sequence, molecular weight, composition, and INCI: not published in the public catalog
Additional fields
Not published in the public catalog
  • Use Semaglutide's canonical name when a method requires a technical identity check.
  • CAS, sequence, molecular weight, composition, and INCI details are not published in the public catalog unless explicitly listed in the identity section.
  • Keep package amount and presentation decisions with the offer rows above; do not infer a concentration or dose from a label.

How Semaglutide is supplied

For Semaglutide, Seqvanta's operational terms are a 24-hour reservation and dispatch within two business days after confirmed payment.

Seller
Seqvanta
How to order
Select a priced package above and continue to checkout.
Dispatch
Within two business days after confirmed payment
Reservation
24 hours after order creation

What this page can and cannot confirm

Semaglutide confirms the catalog identity, package state, and checkout state: a priced package can be selected now. Primary literature, laboratory release criteria, and destination-country review remain separate.

Catalog vs checkout
Currently purchasable in checkout: priced package offers are published
Missing values
Not published in the public catalog
  • Catalog evidence: the name, package fields, and price state shown on this page.
  • Product classification and identity notes are shown where the catalog has a supported match.
  • Unrecorded fields remain not published in the public catalog and should be confirmed before a method depends on them.
  • This is a research-use procurement page, not a treatment, dosing, or human-use guide.

Questions before checkout

Short answers to practical questions

Answers focus on choosing, verifying and ordering this product.

What is Semaglutide?

Semaglutide is listed as a sequence-based material in the Sequence Library catalog. The identity status is catalog identity published; use the published name and package fields rather than extending the page into a sequence, purity, efficacy, or regulatory claim.

Which Semaglutide package should I choose?

Choose the Semaglutide row by total content (10 mg and 30 mg); confirm the selected row in the cart before payment. A larger package price is not automatically a different formulation.

How should a laboratory compare the Semaglutide package options?

For Semaglutide, use the canonical name, package row, and published evidence boundary together. The page supports a sourcing decision; treatment, dosing, and efficacy questions require separate sources.

What exactly is included in a Semaglutide package?

Use the package comparison above for Semaglutide: the selectable rows are 10 mg / 1 vial and 10 mg / 3 units. They show content, form, and container on a mg basis; any unpublished field remains unconfirmed for the selected presentation.

What quality information is published for Semaglutide?

The public product page shows the fields that are available for Semaglutide; any missing SDS, CAS, concentration, or batch document must be requested before payment.

More questions about this product
How much does Semaglutide cost?

Semaglutide has a current published price of $188.50-$455.00 USD per package. Use the package table for the exact row amount; prices are per package, not a concentration or dose.

Is Semaglutide currently purchasable or catalog-only?

Semaglutide is an active catalog product and currently purchasable: the priced package rows above can be selected in checkout.

Is an SDS, CAS number, or concentration published for Semaglutide?

SDS / safety data sheet, CAS number, and concentration for Semaglutide are not published on the public product page unless a selected row states one. Request the relevant document before payment; do not infer these values from the name or package label.

Is species reactivity or authenticity verified for Semaglutide?

Species reactivity and authenticity / chain-of-custody verification are not published for Semaglutide. Request method-specific or batch traceability documentation when your receiving process requires it.

Does Seqvanta publish reviews or a supplier rating for Semaglutide?

No public supplier reviews or rating are published for Semaglutide. Evaluate the product against its identity evidence, documentation, and written fulfillment terms.

Commercial terms

Ordering terms

Review the package, reservation, and dispatch terms before checkout.

Minimum order
$100 merchandise subtotal.
Order reservation
24 hours after an order is created.
Dispatch
Within 2 business days after confirmed payment.

Contact Seqvanta

Questions about Semaglutide?

Need to confirm the Semaglutide package, documents, or delivery? Send the product name and package label through Contact. Use Wholesale for volume or private-label requests.

Contact us